99
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The Value of Sputum 8-Isoprostane in Detecting Oxidative Stress in Mild Asthma

, Ph.D. student, , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D. & , M.D., Ph.D. show all
Pages 149-154 | Published online: 02 Jul 2009

References

  • Kharitonov S A, Barnes P J. Exhaled markers of pulmonary disease. Am J Respir. Crit. Care Med. 2001; 163: 1693–1722
  • Montuschi P, Barnes P J, Roberts L J. Isoprostanes: markers and mediators of oxidative stress. FASEB J 2004; 18: 1791–1800
  • Kharitonov S A, Yates D, Robbins R A, Logan-Sinclair R, Shinebourne E A, Barnes P J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133–135
  • Byrnes C A, Dinarevic S, Shinebourne E A, Barnes P J, Bush A. Exhaled nitric oxide measurements in normal and asthmatic children. Pediatr Pulmonol 1997; 24: 312–318
  • Alving K, Weitzberg E, Lundberg J M. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6: 1368–1370
  • Ludviksdottir D, Janson C, Hogman M, Hedenstrom H, Bjornsson E, Boman G. Exhaled nitric oxide and its relationship to airway responsiveness and atopy in asthma. BHR-Study Group. Respir Med 1999; 93: 552–556
  • Kharitonov S A, Gonio F, Kelly C, Meah S, Barnes P J. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 2003; 21: 433–438
  • Brindicci C, Ito K, Resta O, Pride N B, Barnes P J, Kharitonov S A. Exhaled nitric oxide from lung periphery is increased in COPD. Eur Respir J 2005; 26: 52–59
  • Smith A D, Cowan J O, Brassett K P, Herbison G P, Taylor D R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005; 352: 2163–2173
  • Kharitonov S A, Barnes P J, O'Connor B J. Reduction in exhaled nitric oxide after a single dose of nebulized budesonic in patients with asthma. Am J Respir Crit Care Med 1996; 153: 799
  • Rytila P, Rehn T, Ilumets H, Rouhos A, Sovijarvi A, Myllarniemi M, Kinnula V L. Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD. Respir Res 2006; 7: 69
  • Kharitonov S A. Exhaled markers of inflammatory lung diseases: ready for routine monitoring?. Swiss Med Wkly 2004; 134: 175–192
  • Kharitonov S A, Barnes P J. Clinical aspects of exhaled nitric oxide. Eur Respir J 2000; 16: 781–792
  • Simpson J L, Wood L G, Gibson P G. Inflammatory mediators in exhaled breath, induced sputum, and saliva. Clin Exp Allergy 2005; 35: 1180–1185
  • Kelly F J, Mudway I, Blomberg A, Frew A, Sandstrom T. Altered lung antioxidant status in patients with mild asthma. Lancet 1999; 354: 482–483
  • Rytila P, Pelkonen A S, Metso T, Nikander K, Haahtela T, Turpeinen M. Induced sputum in children with newly diagnosed mild asthma: the effect of 6 months of treatment with budesonide or disodium cromoglycate. Allergy 2004; 59: 839–844
  • NHLBI/WHO. Global strategy for asthma management and prevention. NIH, Bethesida, MarylandUSA 2002, Workshop Report, Publication No 02-3659. 2002
  • Zacharasiewicz A, Wilson N, Lex C, Erin E M, Li A M, Hansel T, Khan M, Bush A. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005; 171: 1077–1082
  • Morrow J D, Hill K E, Burk R F, Nammour T M, Badr K F, Roberts L J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclo-oxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U. S. A. 1990; 87: 9383–9387
  • Janssen L J. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 2001; 280: L1067–L1082
  • Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov S A, Barnes P J. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999; 160: 216–220
  • Wood L G, Garg M L, Simpson J L, Mori T A, Croft K D, Wark P A, Gibson P G. Induced sputum 8-isoprostane concentrations in inflammatory airway diseases. Am J Respir Crit Care Med 2005; 171: 426–430
  • Shahid S K, Kharitonov S A, Wilson N M, Bush A, Barnes P J. Exhaled 8-isoprostane in childhood asthma. Respir Res 2005; 6: 79
  • Montuschi P, Collins J V, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov S A, Barnes P J. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000; 162: 1175–1177
  • Rahman I. Reproducibility of oxidative stress biomarkers in breath condensate: are they reliable?. Eur Respir J 2004; 23: 183–184
  • Horvath I, Hunt J, Barnes P J, Alving K, Antczak A, Baraldi E, Becher G, van Beurden W J, Corradi M, Dekhuijzen R, Dweik R A, Dwyer T, Effros R, Erzurum S, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26: 523–548
  • Crapo R O, Casaburi R, Coates A L, Enright P L, Hankinson J L, Irvin C G, MacIntyre N R, McKay R T, Wanger J S, Anderson S D, Cockcroft D W, Fish J E, Sterk P J. Guidelines for methacholine and exercise challenge testing—1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161: 309–329
  • Sovijarvi A R, Malmberg L P, Reinikainen K, Rytila P, Poppius H. A rapid dosimetric method with controlled tidal breathing for histamine challenge. Repeatability and distribution of bronchial reactivity in a clinical material. Chest 1993; 104: 164–170
  • Pauwels R A, Buist A S, Calverley P M, Jenkins C R, Hurd S S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256–1276
  • Haahtela T, Tamminen K, Malmberg L P, Zetterstrom O, Karjalainen J, Yla-Outinen H, Svahn T, Ekstrom T, Selroos O. Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: a SOMA study. Eur Respir J 2006; 28: 748–755
  • American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999; 160: 2104–2117
  • Baraldi E, de Jongste J C. Measurement of exhaled nitric oxide in children, 2001. Eur Respir J 2002; 20: 223–237
  • Viljanen A A, Halttunen P K, Kreus K E, Viljanen B C. Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest (Suppl) 1982; 159: 5–20
  • Quanjer P H, Tammeling G J, Cotes J E, Pedersen O F, Peslin R, Yernault J C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J (Suppl) 1993; 16: 5–40
  • Djukanovic R, Sterk P J, Fahy J V, Hargreave F E. Standardised methodology of sputum induction and processing. Eur Respir J (Suppl) 2002; 37: 1S–2S
  • Kinnula V L, Ilumets H, Myllarniemi M, Sovijarvi A, Rytila P. 8-isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD. Eur Respir J 2007; 29: 51–55
  • Wood L G, Fitzgerald D A, Gibson P G, Cooper D M, Garg M L. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 2000; 35: 967–974
  • Montuschi P, Ciabattoni G, Paredi P, Pantelidis P, du Bois R M, Kharitonov S A, Barnes P J. 8-isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 1998; 158: 1524–1527
  • American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children—1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999; 160: 2104–2117
  • Liu J, Thomas P S. Exhaled breath condensate as a method of sampling airway nitric oxide and other markers of inflammation. Med Sci Monit 2005; 11: MT53–MT62
  • Pin I, Gibson P G, Kolendowicz R, Girgis-Gabardo A, Denburg J A, Hargreave F E, Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25–29
  • Stockley R A, O'Brien C, Pye A, Hill S L. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 2000; 117: 1638–1645
  • Roberts E M. Does your child have asthma? Parent reports and medication use for pediatric asthma. Arch Pediatr Adolesc Med 2003; 157: 449–455
  • Davis S D. Neonatal and pediatric respiratory diagnostics. Respir Care 2003; 48: 367–384

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.